ANKRD37

Chr 4

ankyrin repeat domain 37

Also known as: Lrp2bp

The ANKRD37 protein localizes to the cytosol, mitochondria, and nucleus, though its specific molecular function remains unclear. Mutations cause autosomal recessive developmental and epileptic encephalopathy with microcephaly, typically presenting in infancy with seizures and severe developmental delays. The gene shows low constraint against loss-of-function variants, consistent with its recessive inheritance pattern.

Summary from RefSeq
Research Assistant →
0
Active trials
7
Pubs (1 yr)
116
P/LP submissions
2%
P/LP missense
1.34
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryANKRD37
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
115 unique Pathogenic / Likely Pathogenic· 47 VUS of 172 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.34LOEUF
pLI 0.001
Z-score 0.87
OE 0.68 (0.371.34)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-0.24Z-score
OE missense 1.07 (0.911.27)
94 obs / 87.7 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.68 (0.371.34)
00.351.4
Missense OE1.07 (0.911.27)
00.61.4
Synonymous OE0.99
01.21.6
LoF obs/exp: 6 / 8.8Missense obs/exp: 94 / 87.7Syn Z: 0.03
DN
0.6550th %ile
GOF
0.73top 25%
LOF
0.3261th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

172 submitted variants in ClinVar

Classification Summary

Pathogenic103
Likely Pathogenic12
VUS47
Likely Benign5
103
Pathogenic
12
Likely Pathogenic
47
VUS
5
Likely Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
103
0
103
Likely Pathogenic
0
2
10
0
12
VUS
0
25
22
0
47
Likely Benign
0
1
4
0
5
Benign
0
0
0
0
0
Total0281390167

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

ANKRD37 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →